CN1076622C - Chinese medicine for curing nephritis - Google Patents
Chinese medicine for curing nephritis Download PDFInfo
- Publication number
- CN1076622C CN1076622C CN99127315A CN99127315A CN1076622C CN 1076622 C CN1076622 C CN 1076622C CN 99127315 A CN99127315 A CN 99127315A CN 99127315 A CN99127315 A CN 99127315A CN 1076622 C CN1076622 C CN 1076622C
- Authority
- CN
- China
- Prior art keywords
- parts
- semen
- chinese medicine
- radix
- nephritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 27
- 201000008383 nephritis Diseases 0.000 title claims abstract description 17
- 206010018367 Glomerulonephritis chronic Diseases 0.000 claims abstract description 16
- 230000001154 acute effect Effects 0.000 claims abstract description 7
- 241000207929 Scutellaria Species 0.000 claims abstract description 4
- 235000004879 dioscorea Nutrition 0.000 claims abstract description 4
- 210000000582 semen Anatomy 0.000 claims description 19
- 229940079593 drug Drugs 0.000 claims description 11
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 5
- 235000005903 Dioscorea Nutrition 0.000 claims description 3
- 241000234273 Dioscorea Species 0.000 claims description 3
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 3
- 241001529739 Prunella <angiosperm> Species 0.000 claims description 3
- 241000545442 Radix Species 0.000 claims description 3
- 239000009636 Huang Qi Substances 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 241001061264 Astragalus Species 0.000 abstract 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 240000007371 Cuscuta campestris Species 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000017803 cinnamon Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 11
- 206010030113 Oedema Diseases 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 208000006750 hematuria Diseases 0.000 description 7
- 210000002700 urine Anatomy 0.000 description 6
- 206010001580 Albuminuria Diseases 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000003907 kidney function Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 3
- 208000000913 Kidney Calculi Diseases 0.000 description 3
- 206010029148 Nephrolithiasis Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- 241001085205 Prenanthella exigua Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 210000005086 glomerual capillary Anatomy 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- KRTSDMXIXPKRQR-AATRIKPKSA-N monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001550 time effect Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a traditional Chinese medicine for treating acute and chronic nephritis, which is prepared from prepared rhizomes of rehmannia, astragalus roots, scutellaria roots, Chinese yams, tuckahoe, coix seeds, dandelion, spica prunellae, plantain seeds, dodder, wolfberry fruits and cinnamon. The present invention has favorable therapeutic effects on acute and chronic nephritis.
Description
The present invention is a kind of medicine for the treatment of nephritis, and it is to be prepared from by Chinese herbal medicine, belongs to the field of Chinese medicines.
Chronic nephritis is the healthy diseases of a kind of serious harm people, and it can occur in all ages and classes stage, is many with young and middle-aged male especially.Its clinical manifestation mainly contains common symptons such as edema, albuminuria, cylinderuria, hematuria, hypertension, and dangerous symptoms such as anemia, chronic renal failure can appear in severe patient.Numerous for many years medical science scholars and expert, though this treatment of diseases method has been done number of research projects, still there are many drawbacks in up to the present existing therapeutic method of traditional Chinese and western medicine.When treating with 17-hydroxy-11-dehydrocorticosterone as doctor trained in Western medicine, can concurrent ulcer, hemorrhage, hypertension or adverse consequences such as azotemia occurs, and when treating with phosphamide, adverse consequencess such as leukocyte then can appear reducing, and also also unstable with the curative effect of western medical treatment, recur easily; For another example, the traditional Chinese medical science generally adopts the decoction treatment by Chinese herbs, and this not only can make patient's sup sorrow in taking the decoction process for a long time, and therapeutic effect is also undesirable.
Theory of Chinese medical science is thought: chronic nephritis is main relevant with vital QI being weakened and pathogen being violent.The weakened body resistance lung, spleen, kidney three of mainly being meant is dirty impaired, and deficiency of the kidney is attached most importance to.Lung loses diffusing respectful the falling of a surname; Dysfunction of the spleen in transportation is had under one's command; Kidney lose Wen Huashui liquid, tonneau urine can, the gate of vitality decline greatly then can not on help in Jiao fortuneization, help the gasification of bladder down so that three warmers water liquid is following normal operation, and be swollen.
The spleen being the foundation of acquired constitution, main department fortuneization is failed the precise and tiny of water distribution paddy, ascending the clear and descending the turbid.The insufficiency of the spleen mistake department of then having under one's command, fortuneization is unable, and ascending the clear and descending the turbid loses power, clear QI being mixed up with turbid QI, cereal nutrient is dirty, and albumen is discharged from urine.
The kidney being the origin of congenital constitution, and kidney person master sting, the dominator of storing essence, and smart part is also.Kidney is subjected to the essence of five ZANG-organs and six FU-organs and hides it.It is not solid that deficiency of the kidney is then sealed the Tibetan, can not collect the essence of five ZANG-organs and six FU-organs gas, and vital essence leaks, and forms albuminuria.
" (Jing Yue's complete work " cloud: " disease such as all edema; be lung, spleen, kidney three dirty relevant diseases " heresy that water is wet, stop up three warmers not go, for a long time and in accumulate damp and hot, damp and hot heresy is strongly fragrant for a long time, the impairment of YIN hematozemia cloudy loses more then that heat more rises, and injures the blood network and causes hematuria, injure the spleen kidney, spleen loses and has under one's command, and kidney unit is not solid, also causes albuminuria.
Prolonged illness people network, the prolonged illness blood stasis, damp-heat accumulation injures venation, and blood stasis then becomes blood stasis.
Modern medicine thinks that the pathological change of nephritis mainly shows glomerular capillary endothelium hyperplasia, basement membrane thickened, the generation degeneration of part glomerule or and then fibrosis, the renal tubules that is attached thereto presents that malnutrition sexually revises or atrophy, thereby albuminuria takes place.
The object of the invention provides a kind of Chinese medicine for the treatment of acute and chronic nephritis.
Medicine of the present invention is prepared from following raw material medicaments: (weight portion)
Radix Rehmanniae Preparata 60-90 part
Radix Astragali 60-90 part
Radix Scutellariae 50-80 part
Rhizoma Dioscoreae 40-60 part
Poria 40-60 part
Semen Coicis 40-60 part
Herba Taraxaci 50-80 part
Spica Prunellae 50-80 part
Semen Plantaginis 40-60 part
Semen Cuscutae 50-80 part
Fructus Lycii 40-60 part
Cortex Cinnamomi 40-60 part
The preferred weight ratio of above-mentioned raw materials each component is:
80 parts in Radix Rehmanniae Preparata
60 parts of the Radixs Astragali
50 parts of Radix Scutellariaes
50 parts of Rhizoma Dioscoreaes
50 parts in Poria
50 parts of Semen Coiciss
60 parts of Herba Taraxacis
60 parts of Spica Prunellaes
50 parts of Semen Plantaginiss
60 parts of Semen Cuscutae
50 parts of Fructus Lycii
50 parts of Cortex Cinnamomis
Medicine of the present invention can be made pharmaceutical dosage form commonly used according to the formulation method of routine, as tablet, and pill, capsule, powder etc.
The preparation method of medicine capsule of the present invention is that above Radix Rehmanniae Preparata, Herba Taraxaci, Spica Prunellae, Semen Plantaginis, Semen Cuscutae, Fructus Lycii Six-element decocting boil, first pass 2 hours, second time 1 hour, filtrate merging is condensed into extractum, and relative density heat surveys 1: 1.20-1.25, and surplus and mix thoroughly with extractum after fine powder is beaten in seven flavor oven dry, oven dry below 80 ℃, break into fine powder, cross 80 mesh sieves and weigh, make capsule.
Drug therapy acute and chronic nephritis of the present invention has good clinical effectiveness.The observation of curative effect of now medicine capsule of the present invention being treated 485 routine acute and chronic nephritis is summarized as follows:
One, ordinary circumstance
The renal calculus shock wave lithotripsy merges acute nephritis person's 297 examples (61.2%), chronic nephritis 188 examples (38.8%) in 485 examples; Male's 232 examples (47.8%), women's 253 examples (52.2%); 108 examples (22.3%) of being in hospital, outpatient service 377 examples (77.7%); 46 years old mean age (22-64 year).
Two, case choice criteria
1, Western medicine diagnose: 1 acute nephritis: renal calculus shock wave lithotripsy medical history is arranged, with the clinical symptoms of anxious hair growth promoting work, as: hematuria, urine protein, frequent micturition, heating, hemogram rising etc., the diagnosis of being not difficult thus.2 chronic nephritis persons have the acute nephritis medical history earlier, add some typical symptoms of chronic nephritis, and if any albuminuria, hematuria, edema and hypertension, blood urea nitrogen and blood creatinine rising etc. are easy to diagnosis.
2, Chinese medical discrimination (mainly referring to chronic nephritis) 1 syndrome of yang deficiency of spleen and kidney: edema is obvious, and color is clear and bright white; Aversion to cold and cold limbs, ache of the spinal column or waist soreness, talalgia, the indigestion and loss of appetite or loose stool of Mental fatigue; Not normal or the menoxenia of sexual function, the tender light fat indentation that has of tongue, deep pulse is fine and smooth or heavy unable late.2 syndrome of deficiency of both qi and yin: lusterless complexion, weak breath is weak, easy catching a cold, afternoon low grade fever or feverish sensation in the palms and soles; Dry mouth and throat or long-term pharyngalgia, pharyngeal dark red; Body of the tongue is red partially, few tongue, thready pulse or a little less than.3 turbid damp diseases: indigestion and loss of appetite, n or V; Sleepy or the spiritual miliaria that withers of heavy sensation of the body, blood urea nitrogen, creatinine are higher.
Three, observation index
1, clinical efficacy
2, the improvement of clinical symptoms and sign
3, untoward reaction and toxic action
Four, curative effect judging standard
1, clinical cure: sings and symptomses such as edema, hematuria disappear, the qualitative lasting feminine gender of urine protein; Renal function is normal.
2, produce effects: sings and symptomses such as edema, hematuria disappear substantially, and urine protein is qualitative to continue to reduce to below the trace; Renal function normally or normal substantially.
3, effective: sings and symptomses such as edema improve, the routine urianlysis progress, and renal function has improvement.
4, invalid: sings and symptomses such as edema improve not obvious, and routine urianlysis does not have progress, and renal function does not have improvement.
Five, Therapeutic Method
Oral medicine capsule of the present invention, 3 times on the one, each 3-5 grain, logotype 2 months was a course of treatment.Acute nephritis is general only with a course of treatment, and two courses of treatment of chronic nephritis majority medications, the individual patient medication reaches 4 courses of treatment.
Six, therapeutic outcome
(1) clinical efficacy
1, examination is controlled acute nephritis 297 examples, clinical cure 289 examples (97.3%), produce effects 8 examples (2.7%).
2, examination is controlled chronic nephritis 188 examples, clinical cure 25 examples (13.3%), produce effects 50 examples (26.6%); Effective 65 examples (34.6%), invalid 48 examples (25.5%).Clinical total effective rate to acute and chronic nephritis is 90.1%.
(2) clinical symptoms and sign: 1, acute nephritis medication one all clinical symptoms and sign are obviously improved, medication left and right sides frequent micturition, hematuria, heating in 20 days disappear, urine protein and hemogram etc. are basic to recover normal, and the eliminating to the renal calculus shock wave lithotripsy has obvious facilitation in addition.2, the general medication 20-30 of chronic nephritis days, edema, lassitude loin and legs, weak breath were unable, parched throat, and symptoms such as poor appetite begin to improve, and most in medication about 2 months, clinical cardinal symptom and sign have clear improvement.
(3) untoward reaction and toxic and side effects; All do not find obvious adverse reaction and toxic and side effects during the medication.
Embodiment:
Choose crude drug in following ratio
80 parts in Radix Rehmanniae Preparata
60 parts of the Radixs Astragali
50 parts of Radix Scutellariaes
50 parts of Rhizoma Dioscoreaes
50 parts in Poria
50 parts of Semen Coiciss
60 parts of Herba Taraxacis
60 parts of Spica Prunellaes
50 parts of Semen Plantaginiss
60 parts of Semen Cuscutae
50 parts of Fructus Lycii
50 parts of Cortex Cinnamomis
Method for making: above Radix Rehmanniae Preparata, Herba Taraxaci, Spica Prunellae, Semen Plantaginis, Semen Cuscutae, Fructus Lycii Six-element decocting boil, first pass 2 hours, second time 1 hour, filtrate merging was condensed into extractum, and relative density heat surveys 1: 1.20-1.25, surplus and mix thoroughly with extractum after fine powder is beaten in seven flavor oven dry, oven dry below 80 ℃ breaks into fine powder, crosses 80 mesh sieves and weighs, about 450 grams, encapsulated, make 1000 promptly.
Claims (2)
1, a kind of Chinese medicine for the treatment of acute and chronic nephritis is characterized in that it is that Chinese medicine by the following weight ratio is prepared from.Radix Rehmanniae Preparata 60-90 part Radix Astragali 60-90 part Radix Scutellariae 50-80 part Rhizoma Dioscoreae 40-60 part Poria 40-60 part Semen Coicis 40-60 part Herba Taraxaci 50-80 part Spica Prunellae 50-80 part Semen Plantaginis 40-60 part Semen Cuscutae 50-80 part Fructus Lycii 40-60 part Cortex Cinnamomi 40-60 part.
2, medicine according to claim 1 is characterized in that the weight ratio of each crude drug is: 50 parts of 50 portions of Cortex Cinnamomis of 60 parts of Fructus Lycii of 50 parts of Semen Cuscutae of 60 portions of Semen Plantaginiss of 60 parts of Spica Prunellaes of 50 parts of Herba Taraxacis of 50 parts of Semen Coiciss of 50 parts of Poria of 50 portions of Rhizoma Dioscoreaes of 60 parts of Radix Scutellariaes of 80 parts of Radixs Astragali of Radix Rehmanniae Preparata.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99127315A CN1076622C (en) | 1999-12-30 | 1999-12-30 | Chinese medicine for curing nephritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99127315A CN1076622C (en) | 1999-12-30 | 1999-12-30 | Chinese medicine for curing nephritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1257736A CN1257736A (en) | 2000-06-28 |
| CN1076622C true CN1076622C (en) | 2001-12-26 |
Family
ID=5284862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99127315A Expired - Fee Related CN1076622C (en) | 1999-12-30 | 1999-12-30 | Chinese medicine for curing nephritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1076622C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103251684B (en) * | 2013-06-09 | 2014-09-03 | 李伟丽 | Medicine composition for treating kidney stone and preparation method of drug composition |
| CN103404659A (en) * | 2013-08-06 | 2013-11-27 | 北京绿源求证科技发展有限责任公司 | Kidney nourishing eatable health tea electuary |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1185959A (en) * | 1996-12-25 | 1998-07-01 | 叶根火 | Chinese medicine for chronic nephritis |
| CN1207907A (en) * | 1997-08-08 | 1999-02-17 | 王建国 | Oral liquid for nephritis |
-
1999
- 1999-12-30 CN CN99127315A patent/CN1076622C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1185959A (en) * | 1996-12-25 | 1998-07-01 | 叶根火 | Chinese medicine for chronic nephritis |
| CN1207907A (en) * | 1997-08-08 | 1999-02-17 | 王建国 | Oral liquid for nephritis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1257736A (en) | 2000-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1169541C (en) | Medicine for treating rheumatoid arthritis | |
| CN101874874B (en) | Chinese medicinal preparation for treating helicobacter pylori concerned chronic gastritis and preparation method thereof | |
| CN1476849A (en) | Medicine composition for promoting blood circulation and removing stasis | |
| CN101062357A (en) | Medicine for treating peptic ulcer and chronic gastritis | |
| CN101095768B (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
| CN116870095B (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN100493572C (en) | Composition of medication for treating diabetes | |
| CN102462834A (en) | Medicinal composition for controlling blood sugar of diabetic | |
| CN102631595A (en) | Medicament for treating II-type diabetes mellitus and preparation method thereof | |
| CN1121867C (en) | Medicine for preventing and treating abortion | |
| CN1054528C (en) | Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin" | |
| CN1137404A (en) | Drug for curing pulmonary tuberculosis | |
| CN1076622C (en) | Chinese medicine for curing nephritis | |
| CN1285380C (en) | Chinese patent medicines for treating chronic superficial gastritis (epigastric pain) and preparation method thereof | |
| CN1253196C (en) | Medicine for treating colitis | |
| CN101569708B (en) | Medicament for treating ischemic heart disease and preparation method thereof | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN1698735A (en) | Medicine for treating psoriasis | |
| CN1966067A (en) | Medicament for treating aplastic anemia | |
| CN1251723C (en) | Pharmaceutical composition for treating idiopathic thrombocytopenic purpura of blood heat type and its preparing process | |
| CN1120011C (en) | Chinese herb medicine composition for treating glomerulonephritis | |
| CN101167915B (en) | Traditional Chinese medicine for treating chronic superficial gastritis and its preparation method | |
| CN100339119C (en) | Traditional Chinese medicine prepns. for treating diabete | |
| CN1712055A (en) | Chinese medicinal preparation (litholytic capsule) for treating urinific calculus | |
| CN100335111C (en) | Medicine for rheumatism and its preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |